Literature DB >> 17235530

Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility.

Maria Rosa Pelizzo1, Domenico Rubello, Isabella Merante Boschin, Andrea Piotto, Costantino Paggetta, Antonio Toniato, Gian Luca De Salvo, Armando Giuliano, Giuliano Mariani, Dario Casara.   

Abstract

PURPOSE: It is a matter of controversy whether prophylactic lymph node dissection improves prognosis and survival in papillary thyroid carcinoma (PTC) patients without suspicion of lymph node metastases either clinically or on ultrasonography. It is possible that in such patients the use of lymphatic mapping and sentinel lymph node (SLN) biopsy, as are employed for other tumours, will be of assistance. The aim of this study was to evaluate the feasibility of preoperative 99mTc-nanocolloid lymphoscintigraphy and an intra-operative SLN procedure in the management of PTC patients.
METHODS: Twenty-five consecutive patients were entered in the study between April 2005 and October 2005. All had a preoperative diagnosis of malignancy obtained by fine-needle aspiration cytology (FNAC), without clinical or ultrasonographic evidence of loco-regional lymph node involvement. Patients underwent preoperative lymphoscintigraphy after the injection of 99mTc-nanocolloid [median 6 MBq (range 4-9 MBq) in 0.1-0.2 ml saline injected intratumorally under ultrasound guidance] and an intra-operative SLN procedure using a hand-held gamma probe. Surgery was performed by the same surgeon in all patients.
RESULTS: Preoperative lymphoscintigraphy identified at least one SLN in all patients. During surgery, using the gamma probe, the surgeon was able to find at least one SLN in all cases. A good correlation was found between preoperative imaging and probe results. Metastasis was found in at least one SLN in 12 (48%) patients. In seven (28%) patients the involved SLN was the most radioactive SLN, while in five (20%) patients a less radioactive SLN was involved by malignancy. Ten of these 12 patients had only micrometastases (<2 mm). Micrometastases were found in the most radioactive SLN in six cases and in less radioactive SLNs in four cases, while in two patients more lymph nodes visualised at lymphoscintigraphy ipsilateral to the primary tumour were sites of metastasis.
CONCLUSION: The rate of nodal involvement was very high in our series: in 48% of patients at least one metastatic lymph node was found. From a technical point of view the intra-operative SLN procedure in PTC patients was easy to perform, without major intra-operative complications. Our promising preliminary experience needs to be confirmed in larger series of patients series with longer follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235530     DOI: 10.1007/s00259-006-0316-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  15 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

Review 2.  Application of the sentinel node concept in urogenital cancer.

Authors:  R M Cabanas
Journal:  Recent Results Cancer Res       Date:  2000

Review 3.  Sentinel lymph node mapping in colorectal cancer--a review.

Authors:  S Saha; D Nora; J H Wong; D Weise
Journal:  Surg Clin North Am       Date:  2000-12       Impact factor: 2.741

4.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

Review 5.  Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature.

Authors:  A P Makar; M Scheistroen; D van den Weyngaert; C G Tropé
Journal:  Int J Gynecol Cancer       Date:  2001 Jul-Aug       Impact factor: 3.437

6.  The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma.

Authors:  M R Pelizzo; I M Boschin; A Toniato; P Bernante; A Piotto; A Rinaldo; A Ferlito
Journal:  Acta Otolaryngol       Date:  2001-04       Impact factor: 1.494

7.  Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid.

Authors:  A R Shaha; J P Shah; T R Loree
Journal:  Am J Surg       Date:  1996-12       Impact factor: 2.565

8.  Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma.

Authors:  L Rettenbacher; P Sungler; D Gmeiner; H Kässmann; G Galvan
Journal:  Eur J Nucl Med       Date:  2000-09

9.  Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma

Authors: 
Journal:  Clin Nucl Med       Date:  1999-10       Impact factor: 7.794

10.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more
  11 in total

1.  Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.

Authors:  Paolo Carcoforo; Davide Sortini; Viola Zulian; Annabella Blotta; Roberta Rossi; Luciano M Feggi
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement.

Authors:  Amparo Garcia-Burillo; Isabel Roca Bielsa; Oscar Gonzalez; Carles Zafon; Monica Sabate; Josep Castellvi; Xavier Serres; Carmela Iglesias; Ramon Vilallonga; Enric Caubet; Jose Manuel Fort; Jordi Mesa; Manuel Armengol; Joan Castell-Conesa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-02       Impact factor: 9.236

3.  99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients.

Authors:  M R Pelizzo; A Toniato; N Sorgato; A Losi; F Torresan; I Merante Boschin
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

Review 4.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

5.  Tc-99m radio-guided completion thyroidectomy for differentiated thyroid carcinoma.

Authors:  Savaş Karyağar; Oğuzhan Karatepe; Omer Bender; Mehmet Mulazımoğlu; Tevfik Ozpaçaci; Ercan Uyanık; Sevda S Karyağar; Orhan Yalçın; Yaşar Ozdenkaya
Journal:  Indian J Nucl Med       Date:  2010-01

6.  99Tc Nanocolloid sentinel node procedure in thyroid carcinoma.

Authors:  Isabella Merante Boschin; Antonio Toniato; Andrea Piotto; Eric Casal Ide; Dario Casara; AnnaMaria Guolo; Domenico Rubello; MariaRosa Pelizzo
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

Review 7.  Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.

Authors:  Ludovico Maria Garau; Domenico Rubello; Alice Ferretti; Giuseppe Boni; Duccio Volterrani; Gianpiero Manca
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

8.  Sentinel lymph node biopsy for papillary thyroid cancer: the effect of dose, tracer and application of massage.

Authors:  Abbas Alibakhshi; Saeed Farzanehfar; Mahya Zarei; Mohammad Eftekhari; Maziar Motiee; Maryam Naseri; Mehrshad Abbasi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021

9.  Feasibility of sentinel lymph node dissection using Tc-99m phytate in papillary thyroid carcinoma.

Authors:  Se Hyun Paek; Ka Hee Yi; Su-Jin Kim; June Young Choi; Kyu Eun Lee; Young Joo Park; Do-Joon Park; Keon Wook Kang; June-Key Chung
Journal:  Ann Surg Treat Res       Date:  2017-10-27       Impact factor: 1.859

10.  Sentinel lymph node in thyroid tumors - own experience.

Authors:  Krzysztof Kaczka; Bartłomiej Luks; Jakub Jasion; Lech Pomorski
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.